CLVT

Clarivate Plc (CLVT) | Rumor.io

Clarivate

CLVT

Attention (50-day avg)0%

Attention rank (50-day avg)#3,838

Bullish sentiment (50-day avg)100%

Price to earnings ratio30.8

Market capitalization1.1B

Earnings per share-0.52

Dividend yield (TTM)—

Revenue (annual)2.5B

Net income (annual)-201.1M

Social

What share of all stock conversation is about CLVT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Jul 29

Clarivate's Q2 2026 earnings were defined by a massive strategic move to divest its Life Sciences & Healthcare segment for $600 million, which is approximately 40% of the company's market cap.
The company reported a net loss of $268.6 million and a revenue decline of 5.5% year-over-year, with organic revenue decreasing by 1.5%.
Clarivate's stock price dropped by 15.2% as market participants reduced risk exposure, with the share price falling to $2.04, but the company delivered continued progress on strategic and financial priorities through its Value Creation Plan.

Generated by AI

Sentiment

Of the messages about CLVT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	63.78% -10.51
Bearish	—	—	—	36.22% +10.51

Apr 29

Clarivate Plc's Q1'26 earnings exceeded estimates, with revenue reaching $585.5M (vs. est. $568.78M) and EPS at $0.18 (vs. est. $0.14).
The company's FY guidance was reaffirmed, with revenue expected to be in the range of $2.30B-$2.42B (vs. est. $2.36B) and EPS between $0.70-$0.80 (vs. est. $0.72).
Clarivate's shares rose 5.1% following the earnings release, indicating a positive market reaction to the company's Q1 performance.

Generated by AI

Topics

Of the messages about CLVT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	53.85%
Technical Analysis	—	—	0%	14.84%
Controversies	—	—	0%	0.55%
Earnings	—	—	0%	7.69%
Analysts	—	—	0%	12.09%
Macro	—	—	0%	10.99%

Announcements· Feb 24

Clarivate Plc ($CLVT) reported Q4 & FY2025 results, with FY25 revenue of $2.46B (-4.0% YoY) and adj. EBITDA of $1.00B (-5.5% YoY).
The company achieved 88% recurring revenue mix, improved organic ACV by 1.8%, and generated $365.3M in free cash flow.
Clarivate is pursuing the sale of its Life Sciences & Healthcare division and expects 2026 to bring 10% higher FCF and margin expansion.

Controversies· Feb 15

A class-action lawsuit was filed against Clarivate Plc (CLVT) for alleged securities fraud, with investors having an opportunity to lead the lawsuit.
Shareholders who suffered losses in CLVT are reminded of the upcoming deadline to join the lawsuit.
CLVT investors are advised to take advantage of the opportunity to lead the securities fraud lawsuit against Clarivate Plc.

Generated by AI

Community

Of the messages about CLVT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	100%	16.58%
Newcomers	—	0%	0%	83.42%

Regulars· Feb 27

Clarivate Plc's Q4 2023 earnings report showed a 10% increase in EPS to $0.23, beating expectations by $0.02.
The company's revenue grew 1% to $683.7M, but guided FY-2024 revenue below consensus.
Despite the shortfall, Clarivate Plc's stock has shown positive growth over the past 30 days, improving by 1.24%, continuing a positive trend for the company.

Newcomers· Jul 17

Newcomers to the CLVT asset are expressing caution, with one user stating "Here we go" in relation to the asset.
Some users are concerned about the asset's potential, with one user repeating "Here we go" as if anticipating a significant event.
CLVT's price is being discussed, with one user's mention of "Here we go" implying a focus on the asset's movement.

Generated by AI

Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding 3.875% Senior Secured Notes due 2028 (the "Notes") for aggregate principal amount of up to $75,000,000 (the "Maximum Amount"), upon the terms and subject to the conditions set

5d agoYahoo Finance

Clarivate announces tender offer pricing for 2028 notes

6d agoInvesting.com

Universal Display Corporation Congratulates Stephen R. Forrest and Mark E. Thompson on Being Named 2026 Clarivate Citation Laureates

EWING, N.J., September 22, 2026--UDC congratulates Stephen R. Forrest and Mark E. Thompson on being named 2026 Clarivate Citation Laureates.

7d agoYahoo Finance

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

(PR Newswire) - Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third quarter 2026 before the market opens on Tuesday, November 3, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.

8d agoYahoo Finance

Clarivate Subsidiary Launches Cash Tender Offer for Senior Secured Notes

Clarivate (CLVT) subsidiary Clarivate Science has launched a cash tender offer for its 3.875% senior

12d agofinance.yahoo.com

Also Discussed

Investors talking about CLVT also mention

#	Name	Attention
1	Skillsoft Corp. Class A Common StockSKIL	0%0
2	Cannae Holdings, Inc.CNNE	0%new
3	BrightSpring Health Services, Inc.BTSG	0%0
4	Corebridge Financial Inc.CRBG	0%0
5	Alight Inc. Class A Common StockALIT	0%new
6	Avantor, Inc.AVTR	0%0
7	Compass Therapeutics, Inc.CMPX	0%new
8	Capri Holdings Ltd.CPRI	0%new
9	CBIZ, Inc.CBZ	0%0
10	Vestis CorporationVSTS	0%new

Clarivate Plc

Technology
Information Technology Services

Clarivate Plc is a global information services and analytics company, recognized for providing comprehensive intellectual property and scientific information solutions. Its primary function is to deliver valuable insights that help businesses, researchers, and academic institutions make informed decisions by leveraging high-quality data and analytics. The company serves a broad spectrum of sectors, including the legal, pharmaceutical, biotechnology, academic, and financial industries, facilitating advancements in research, commercialization, and innovation. Among its notable offerings are the Web of Science, a premier research database; and Derwent, a renowned source for patent information. Clarivate plays a critical role in the market by helping organizations navigate complex information ecosystems, enabling them to enhance productivity, protect and grow intellectual assets, and accelerate the pace of innovation. The company operates in an increasingly data-driven world, positioning itself as a key enabler of advancements in technology, healthcare, and scientific research.

Website

Location

70 St. Mary Axe

London, EC3A 8BE

United Kingdom

Social

What share of all stock conversation is about CLVT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Jul 29

Clarivate's Q2 2026 earnings were defined by a massive strategic move to divest its Life Sciences & Healthcare segment for $600 million, which is approximately 40% of the company's market cap.
The company reported a net loss of $268.6 million and a revenue decline of 5.5% year-over-year, with organic revenue decreasing by 1.5%.
Clarivate's stock price dropped by 15.2% as market participants reduced risk exposure, with the share price falling to $2.04, but the company delivered continued progress on strategic and financial priorities through its Value Creation Plan.

Generated by AI

Sentiment

Of the messages about CLVT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	63.78% -10.51
Bearish	—	—	—	36.22% +10.51

Apr 29

Clarivate Plc's Q1'26 earnings exceeded estimates, with revenue reaching $585.5M (vs. est. $568.78M) and EPS at $0.18 (vs. est. $0.14).
The company's FY guidance was reaffirmed, with revenue expected to be in the range of $2.30B-$2.42B (vs. est. $2.36B) and EPS between $0.70-$0.80 (vs. est. $0.72).
Clarivate's shares rose 5.1% following the earnings release, indicating a positive market reaction to the company's Q1 performance.

Generated by AI

Topics

Of the messages about CLVT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	53.85%
Technical Analysis	—	—	0%	14.84%
Controversies	—	—	0%	0.55%
Earnings	—	—	0%	7.69%
Analysts	—	—	0%	12.09%
Macro	—	—	0%	10.99%

Announcements· Feb 24

Clarivate Plc ($CLVT) reported Q4 & FY2025 results, with FY25 revenue of $2.46B (-4.0% YoY) and adj. EBITDA of $1.00B (-5.5% YoY).
The company achieved 88% recurring revenue mix, improved organic ACV by 1.8%, and generated $365.3M in free cash flow.
Clarivate is pursuing the sale of its Life Sciences & Healthcare division and expects 2026 to bring 10% higher FCF and margin expansion.

Controversies· Feb 15

A class-action lawsuit was filed against Clarivate Plc (CLVT) for alleged securities fraud, with investors having an opportunity to lead the lawsuit.
Shareholders who suffered losses in CLVT are reminded of the upcoming deadline to join the lawsuit.
CLVT investors are advised to take advantage of the opportunity to lead the securities fraud lawsuit against Clarivate Plc.

Generated by AI

Community

Of the messages about CLVT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	100%	16.58%
Newcomers	—	0%	0%	83.42%

Regulars· Feb 27

Clarivate Plc's Q4 2023 earnings report showed a 10% increase in EPS to $0.23, beating expectations by $0.02.
The company's revenue grew 1% to $683.7M, but guided FY-2024 revenue below consensus.
Despite the shortfall, Clarivate Plc's stock has shown positive growth over the past 30 days, improving by 1.24%, continuing a positive trend for the company.

Newcomers· Jul 17

Newcomers to the CLVT asset are expressing caution, with one user stating "Here we go" in relation to the asset.
Some users are concerned about the asset's potential, with one user repeating "Here we go" as if anticipating a significant event.
CLVT's price is being discussed, with one user's mention of "Here we go" implying a focus on the asset's movement.

Generated by AI

Clarivate

Social

Jul 29

Sentiment

Apr 29

Topics

Announcements· Feb 24

Controversies· Feb 15

Community

Regulars· Feb 27

Newcomers· Jul 17

News

Clarivate Plc stock hits 52-week low at 1.65 USD

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate announces tender offer pricing for 2028 notes

Universal Display Corporation Congratulates Stephen R. Forrest and Mark E. Thompson on Being Named 2026 Clarivate Citation Laureates

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

Clarivate Subsidiary Launches Cash Tender Offer for Senior Secured Notes

Also Discussed

Clarivate Plc

Company Information

Location

News

Clarivate Plc stock hits 52-week low at 1.65 USD

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate announces tender offer pricing for 2028 notes

Universal Display Corporation Congratulates Stephen R. Forrest and Mark E. Thompson on Being Named 2026 Clarivate Citation Laureates

Clarivate to Report Third Quarter 2026 Results on November 3, 2026

Clarivate Subsidiary Launches Cash Tender Offer for Senior Secured Notes

Also Discussed

Social

Jul 29

Sentiment

Apr 29

Topics

Announcements· Feb 24

Controversies· Feb 15

Community

Regulars· Feb 27

Newcomers· Jul 17